Osteoclasts and Biomaterials

There is a growing market of biomaterials for orthopedic applications. As soon as these materials are surgically introduced into the constantly remodeling bone of the patient, they start to interact with the local cells: osteoblasts and osteoclasts. At the first glance, the bone building osteoblasts seem to be the more important cells for osseointegration of implants. However, it is mainly the bone resorbing action of osteclasts that determines the longevity of the implant. In this paper, we give a short overview over the current understanding of osteoclast biology; we review the interaction between biomaterials, biomaterial particles and osteoclasts, and the effects of treatment with antiosteoclastic agents like bisphosphonates on biomaterial implant healing.

[1]  D. Carnes,et al.  Ability of deproteinized cancellous bovine bone to induce new bone formation. , 2000, Journal of periodontology.

[2]  G. I. Anderson,et al.  In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study. , 2002, The International journal of oral & maxillofacial implants.

[3]  H. Ozawa,et al.  Effects of osteocytes on osteoinduction in the autogenous rib graft in the rat mandible. , 1994, Bone.

[4]  N. Rushton,et al.  Toxicity of particulate silicon carbide for macrophages, fibroblasts and osteoblast-like cells in vitro. , 1995, Bio-medical materials and engineering.

[5]  L. Notarangelo,et al.  Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis , 2000, Nature Genetics.

[6]  A. Schindeler,et al.  Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro. , 2005, Biochemical and biophysical research communications.

[7]  E. Schwarz,et al.  Efficacy of Etanercept for Wear Debris‐Induced Osteolysis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  A. Schilling,et al.  Resorbability of bone substitute biomaterials by human osteoclasts. , 2004, Biomaterials.

[9]  D. Murray,et al.  Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption , 1998, Annals of the rheumatic diseases.

[10]  Q. Zheng,et al.  Biodegradation of tricalcium phosphate ceramics by osteoclasts. , 1998, Journal of Tongji Medical University = Tong ji yi ke da xue xue bao.

[11]  Di Chen,et al.  Bone Morphogenetic Proteins , 2004, Growth factors.

[12]  T. Martin,et al.  Osteoclast-derived activity in the coupling of bone formation to resorption. , 2005, Trends in molecular medicine.

[13]  M. Lee,et al.  Malignant infantile osteopetrosis initially presenting with neonatal hypocalcemia: case report , 2002, Annals of Hematology.

[14]  G. Saxler,,et al.  Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. , 2005, Journal of biomedical materials research. Part A.

[15]  M. Horton,et al.  Modulation of vitronectin receptor‐mediated osteoclast adhesion by Arg‐Gly‐Asp peptide analogs: A structure‐function analysis , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  T. Suda,et al.  Differentiation and function of osteoclasts. , 2003, The Keio journal of medicine.

[17]  J. A. Engels,et al.  In situ complement activation by polyethylene wear debris. , 2001, Journal of biomedical materials research.

[18]  C. Minkin,et al.  Role of the Osteoclast at the Bone-Implant Interface , 1999, Advances in dental research.

[19]  J. Rungby,et al.  Hormone Replacement Therapy Prevents Osteoclastic Hyperactivity: A Histomorphometric Study in Early Postmenopausal Women , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  S. Miscia,et al.  Implant surface roughness influences osteoclast proliferation and differentiation. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[21]  G. Daculsi,et al.  Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/beta-tricalcium phosphate ratios. , 1997, Biomaterials.

[22]  Masaki Noda,et al.  Unloading Induces Osteoblastic Cell Suppression and Osteoclastic Cell Activation to Lead to Bone Loss via Sympathetic Nervous System* , 2005, Journal of Biological Chemistry.

[23]  V. Goldberg,et al.  Adherent Endotoxin on Orthopedic Wear Particles Stimulates Cytokine Production and Osteoclast Differentiation , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  F. Monchau,et al.  In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate. , 2002, Biomolecular engineering.

[25]  C. Ruff,et al.  Who's afraid of the big bad Wolff?: "Wolff's law" and bone functional adaptation. , 2006, American journal of physical anthropology.

[26]  A. Schilling,et al.  Central control of bone mass: brainstorming of the skeleton. , 2001, Advances in experimental medicine and biology.

[27]  C. V. van Blitterswijk,et al.  Osteoclastic resorption of biomimetic calcium phosphate coatings in vitro. , 2001, Journal of biomedical materials research.

[28]  D. Murray,et al.  Macrophages stimulate bone resorption when they phagocytose particles. , 1990, The Journal of bone and joint surgery. British volume.

[29]  A. Schulz,et al.  Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man , 2001, Cell.

[30]  S. Stupp,et al.  Nanoapatite and organoapatite implants in bone: histology and ultrastructure of the interface. , 1995, Journal of biomedical materials research.

[31]  J. Jurvelin,et al.  Effect of Alendronate on Periprosthetic Bone Loss After Total Knee Arthroplasty: A One-Year, Randomized, Controlled Trial of 19 Patients , 2002, Calcified Tissue International.

[32]  A. Mohn,et al.  Autosomal malignant osteopetrosis. From diagnosis to therapy. , 2004, Minerva pediatrica.

[33]  C. Knabe,et al.  Development of multinuclear giant cells during the degradation of Bioglass particles in rabbits. , 2004, Journal of biomedical materials research. Part A.

[34]  W. Walsh,et al.  Multiaxial Pedicle Screw Designs: Static and Dynamic Mechanical Testing , 2004, Spine.

[35]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[37]  M. Markiewicz,et al.  Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge. , 2005, Journal of the American Dental Association.

[38]  松岡 秀明.  Osteoclastic resorption of bone-like apatite formed on a plastic disk as an in vitro assay system , 1999 .

[39]  C. Shih,et al.  Periprosthetic fractures of the greater trochanter through osteolytic cysts with uncemented MicroStructured Omnifit prosthesis , 2005, Acta orthopaedica.

[40]  Rueger Jm.  Bone substitution materials. Current status and prospects , 1998 .

[41]  H. Frost.  Tetracycline-based histological analysis of bone remodeling , 2005, Calcified Tissue Research.

[42]  Y. Fujikawa,et al.  Effect of particle size on macrophage-osteoclast differentiation in vitro , 2001, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[43]  P. Rodrigues,et al.  Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients , 2004, Prostate Cancer and Prostatic Diseases.

[44]  M. Kumegawa,et al.  Activation of osteoclast-mediated bone resorption by the supernatant from a rabbit synovial cell line in response to polyethylene particles. , 1996, Journal of Biomedical Materials Research.

[45]  D. Murray,et al.  Increased osteoclastic differentiation by PMMA particle-associated macrophages. Inhibitory effect by interleukin 4 and leukemia inhibitory factor. , 1996, Acta orthopaedica Scandinavica.

[46]  Anders Isaksson,et al.  Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  J. Davies,et al.  Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro. , 1993, Biomaterials.

[48]  F. Lin,et al.  The influence of hydroxyapatite particles on osteoclast cell activities. , 1999, Journal of biomedical materials research.

[49]  Robert Langer,et al.  In vivo engineering of organs: the bone bioreactor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Benghuzzi,et al.  Bioceramics surface modification by means of osteoclasts in culture. , 1999, Biomedical sciences instrumentation.

[51]  L. Hofbauer,et al.  Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease. , 2005, Biochemical and biophysical research communications.

[52]  R. Baron,et al.  Dissociation between bone resorption and bone formation in osteopenic transgenic mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. McGuire,et al.  Rickets and osteopetrosis: the osteosclerotic (oc) mouse. , 1985, Clinical orthopaedics and related research.

[54]  R. Baron,et al.  Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. , 2000, Bone.

[55]  Arndt F Schilling,et al.  Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.

[56]  G. Saxler,,et al.  The effect of simvastatin on polyethylene particle-induced osteolysis. , 2005, Biomaterials.

[57]  Sakae Tanaka,et al.  c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption , 1996, Nature.

[58]  S. J. Jones,et al.  The resorption of biological and non-biological substrates by cultured avian and mammalian osteoclasts , 2004, Anatomy and Embryology.

[59]  M. Helfrich.  Osteoclast diseases and dental abnormalities. , 2005, Archives of oral biology.

[60]  M. Horton,et al.  Endocytic trafficking in actively resorbing osteoclasts , 2004, Journal of Cell Science.

[61]  J. Rueger.  [Bone substitution materials. Current status and prospects]. , 1998, Der Orthopade.

[62]  S. Yamasaki,et al.  Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty , 2005, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[63]  J. Jansen,et al.  Osteoclastic resorption of calcium phosphate coatings applied with electrostatic spray deposition (ESD), in vitro. , 2005, Journal of biomedical materials research. Part A.

[64]  R. Ganz,et al.  Wear particles and surface topographies are modulators of osteoclastogenesis in vitro. , 2005, Journal of biomedical materials research. Part A.

[65]  M. Amling,et al.  Zellbiologie des Osteoklasten und molekulare Mechanismen der Knochenresorption* , 1996, Der Pathologe.